Clinical Trial Update: Effect of olmesaRtan on Walking distancE and quaLIty of lifE in Peripheral Artery Disease Patients With Hypertension Treated For Intermittent Claudication (RELIEF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of olmesartan on walking distance and quality of life in patients with peripheral artery disease and intermittent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Peripheral Artery Disease

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: Yonsei University | Conditions: Peripheral Artery Disease With Intermittent Claudication | Phase 4 | Status: TERMINATED